Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Renal Care

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

Therapies
  • Acute Therapy

    Organ support and blood purification therapies are essential to improving patient outcomes in the ICU.

  • Peritoneal Dialysis

    Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.

  • Hemodialysis

    Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.

  • HDx Therapy

    HDx - also known as expanded hemodialysis - is an innovative therapy that effectively targets the removal of large middle molecules.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Data & Insights

Groundbreaking research and inspirational patient stories.

  • Clinical Data

    Explore the research enabling innovative Renal Care.

  • Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Resource Library

    Access resources for Baxter’s broader Renal Care portfolio.

Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

clinical-data-module-image2.png
Clinical Data – PD •

Remote Patient Management technology enhances the experience of Automated Peritoneal Dialysis

The flexibility that Peritoneal Dialysis (PD) offers renal patients allows them to maintain their lifestyle and independence. When Automated PD is combined with Remote Patient Monitoring, the flexibility is further enhanced and is associated with the potential to improve clinical outcomes and adherence.

Read More

A Focus on Clinical Research

HDx

Medium Cut-Off Dialyzer versus Eight Hemodiafiltration Dialyzers: Comparison Using a Global Removal Score - Maduell F et al.

View resource
HDx

Membrane Innovation in Dialysis - Boschetti-de-Fierro A et al.

View resource
HDx

Membrane innovation: closer to native kidneys - Storr M, Ward RA.

View resource
HDx

Performance of hemodialysis with novel medium cut-off dialyzers - Kirsch AH, et al.

Learn More
HDx

Pyrogen retention: Comparison of the novel medium cut-off (MCO) membrane with other dialyser membranes

View resource
HDx

Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration

View resource
HDx

In Vitro Cytokine Removal: Comparison of Conventional High-Flux Dialyzers and Middle-Cut-Off Dialyzer (Theranova HDx)

View resource
HDx

Removal of Middle Molecules Using Medium Cut-Off Membranes in Hemodialysis Mode vs. High-Flux Membranes in Post-Dilutional Online Hemodiafiltration Mode: The REMOC Study

View resource
HDx

The Comparison of Vancomycin Removal Between Medium Cut-Off(Theranova®) and Other Dialyzers

View resource
HDx

The Proteome of Hemodialysis Membranes: A Discovery Proteomic Pilot Study

View resource
HDx

Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over study

View resource
HDx

A Randomised Study Investigating the Effect of Medium Cut-Off Haemodialysis on Markers of Vascular Health Compared with Online Haemodiafiltration (MoDal Study)

View resource